Reuters logo
BRIEF-Pluristem provides shareholder update on corporate, clinical developments
May 22, 2017 / 11:40 AM / 6 months ago

BRIEF-Pluristem provides shareholder update on corporate, clinical developments

May 22 (Reuters) - Pluristem Therapeutics Inc:

* Pluristem provides shareholder update on corporate and clinical developments

* Says study results showed that all three doses of PLX-R18 improved survival rates compared to control group

* Pluristem Therapeutics -as of March 31, 2017, co had $33.1 million in cash, cash equivalents, bank deposits, restricted deposits and marketable securities

* Pluristem Therapeutics Inc - does not expect necessary clarifications regarding agreement with innovative medical to be provided by end of H1/2017 Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below